Slow Launch Of Xcid Antacid Spurs Matrixx To Marketing Changes
This article was originally published in The Tan Sheet
Executive Summary
Matrixx Initiatives plans product-sampling and coupon-marketing activities as well as store displays in response to "small" sales of its latest product, Xcid antacid, the firm says
You may also be interested in...
Matrixx Initiatives Thrives In Cough/Cold, But Eyes Off-Season Relief
Matrixx Initiatives is looking at new products and possible acquisitions to help counter-balance the seasonality of its Zicam cough/cold, allergy and cold sore line, a goal that has so far eluded the firm
Matrixx Initiatives Thrives In Cough/Cold, But Eyes Off-Season Relief
Matrixx Initiatives is looking at new products and possible acquisitions to help counter-balance the seasonality of its Zicam cough/cold, allergy and cold sore line, a goal that has so far eluded the firm
Matrixx Initiatives Thrives In Cough/Cold, But Eyes Off-Season Relief
Matrixx Initiatives is looking at new products and possible acquisitions to help counter-balance the seasonality of its Zicam cough/cold, allergy and cold sore line, a goal that has so far eluded the firm